Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.08.2019 | Case report

Cotrimoxazole/dapsone/pyrimethamine

Erythematous rash and haematological disorders: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 55-year-old man developed erythematous rash during treatment with cotrimoxazole, leucopenia and thrombocytopenia during treatment with pyrimethamine for toxoplasmic encephalitis (TE) and developed agranulocytosis during treatment with dapsone for Pneumocystis pneumonia (PCP) prophylaxis [times to reactions onsets and outcomes not stated; not all dosages and routes stated]. …
Literatur
Zurück zum Zitat Hodgson HA, et al. Successful treatment of cerebral toxoplasmosis using pyrimethamine oral solution compounded from inexpensive bulk powder. Open Forum Infectious Diseases 5: No. 4, Apr 2018. Available from: URL: http://doi.org/10.1093/ofid/ofy055 - USA Hodgson HA, et al. Successful treatment of cerebral toxoplasmosis using pyrimethamine oral solution compounded from inexpensive bulk powder. Open Forum Infectious Diseases 5: No. 4, Apr 2018. Available from: URL: http://​doi.​org/​10.​1093/​ofid/​ofy055 - USA
Metadaten
Titel
Cotrimoxazole/dapsone/pyrimethamine
Erythematous rash and haematological disorders: case report
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-65885-3

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Methotrexate

Case report

Tacrolimus

Case report

Progesterone

Case report

Empagliflozin